Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis (MIRA-3)
Clinical trial NCT05134974 · COMPLETED
Trial details
- NCT number
- NCT05134974
- Sponsor
- Ocuphire Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-18
- Primary completion
- 2022-03-18
- Enrollment
- 368
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.